- Home
- SPRY vs MFA Comparison
SPRY vs MFA Comparison
Compare SPRY & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- MFA
- Stock Information
- Founded
- SPRY 2015
- MFA 1997
- Country
- SPRY United States
- MFA United States
- Employees
- SPRY N/A
- MFA N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- MFA Real Estate Investment Trusts
- Sector
- SPRY Health Care
- MFA Real Estate
- Exchange
- SPRY Nasdaq
- MFA Nasdaq
- Market Cap
- SPRY 1.1B
- MFA 1.1B
- IPO Year
- SPRY N/A
- MFA N/A
- Fundamental
- Price
- SPRY $12.56
- MFA $10.64
- Analyst Decision
- SPRY Strong Buy
- MFA Buy
- Analyst Count
- SPRY 4
- MFA 5
- Target Price
- SPRY $26.00
- MFA $13.50
- AVG Volume (30 Days)
- SPRY 1.4M
- MFA 929.4K
- Earning Date
- SPRY 03-20-2025
- MFA 02-19-2025
- Dividend Yield
- SPRY N/A
- MFA 13.26%
- EPS Growth
- SPRY N/A
- MFA N/A
- EPS
- SPRY N/A
- MFA 1.60
- Revenue
- SPRY $2,568,000.00
- MFA $366,192,000.00
- Revenue This Year
- SPRY $67,363.34
- MFA N/A
- Revenue Next Year
- SPRY $511.99
- MFA $14.93
- P/E Ratio
- SPRY N/A
- MFA $6.60
- Revenue Growth
- SPRY 8460.00
- MFA 164.50
- 52 Week Low
- SPRY $6.29
- MFA $9.36
- 52 Week High
- SPRY $18.51
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- SPRY 44.57
- MFA 56.59
- Support Level
- SPRY $11.00
- MFA $10.06
- Resistance Level
- SPRY $14.87
- MFA $10.57
- Average True Range (ATR)
- SPRY 0.95
- MFA 0.19
- MACD
- SPRY 0.04
- MFA 0.08
- Stochastic Oscillator
- SPRY 31.26
- MFA 92.91
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.